journal
Journals Pharmaceutical Development and...

Pharmaceutical Development and Technology

https://read.qxmd.com/read/38014878/emulgels-a-promising-topical-drug-delivery-system-for-arthritis-management-and-care
#41
REVIEW
Aditi Sinha, Unnati Garg, Upendra Nagaich, Amit Chaudhary, Manisha Pandey, Neha Jain
Emulgels, hybrid formulations of emulsions and gels, offer distinct benefits viz. extended release, enhanced bioavailability, and targeted drug delivery to inflamed joints, thereby minimizing systemic side effects, and maximizing therapeutic efficacy in targeting the diseases. Oral medications and topical creams have limitations viz. limited permeation, efficacy, and side effects. Arthritis is a prevalent chronic inflammatory disorder affecting a substantial global population of about 350 million necessitating the exploration of innovative and effective treatment approaches...
November 28, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/38014703/solusomes-novel-soluplus%C3%A2-enriched-nano-vesicular-carriers-for-improving-the-oral-bioavailability-of-candesartan-cilexetil
#42
JOURNAL ARTICLE
Mohammed Abdallah, Aysha Sayed Mohamed, Mina Ibrahim Tadros, Mohamed El-Nabarawi, Mai Ahmed Tawfik
Candesartan cilexetil (CAN) is administered for treating hypertension and heart failure. CAN suffers poor oral bioavailability, owing to limited aqueous solubility, and first-pass metabolism. Solusomes (novel Soluplus® enriched nano-vesicular carriers) combine the merits of Soluplus® , and the traditional liposomes. They were explored to increase CAN solubility, allow a high drug release rate, and improve the oral drug bioavailability. Solusomes were developed via thin film hydration technique utilizing lipid (phosphatidylcholine; PC) and polymeric solubilizer (Soluplus® ; Solu)...
November 28, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37987762/effect-of-variables-on-exemestane-loaded-albumin-nanoparticles-statistical-optimization-and-anti-cancer-activity-in-mcf-7-cell-lines
#43
JOURNAL ARTICLE
Darshan Vyas, Sarika Wairkar
This research aimed to evaluate the effect of variables on exemestane-loaded bovine serum albumin nanoparticles (EXE-BSA NPs) to improve anti-breast cancer activity. EXE-BSA NPs were optimized using 32 factorial design wherein the concentration of BSA (X1) and sonication time (X2) were independent variables and particle size (Y1) and %w/w entrapment efficiency (Y2) were dependent variables. The statistical optimization revealed a significant effect of BSA concentration on both variables, whereas sonication time affected only particle size...
November 21, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37987717/fabrication-of-dissolving-microneedles-for-transdermal-delivery-of-protein-and-peptide-drugs-polymer-materials-and-solvent-casting-micromoulding-method
#44
REVIEW
Rr Kirana Andranilla, Qonita Kurnia Anjani, Pietradewi Hartrianti, Ryan F Donnelly, Delly Ramadon
Proteins and peptides are rapidly developing pharmaceutical products and are expected to continue growing in the future. However, due to their nature, their delivery is often limited to injection, with drawbacks such as pain and needle waste. To overcome these limitations, microneedle technology is developed to deliver protein and peptide drugs through the skin. One type of microneedle, known as dissolving microneedles, has been extensively studied for delivering various proteins and peptides, including ovalbumin, insulin, bovine serum albumin, polymyxin B, vancomycin, and bevacizumab...
November 21, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37975846/nose-to-brain-drug-delivery-for-the-treatment-of-glioblastoma-multiforme-nanotechnological-interventions
#45
REVIEW
Nitish Kumar, Bharat Khurana, Daisy Arora
Glioblastoma multiforme (GBM) is the most aggressive malignant brain tumor with a short survival rate. Extensive research is underway for the last two decades to find an effective treatment for GBM but the tortuous pathophysiology, development of chemoresistance, and presence of BBB are the major challenges, prompting scientists to look for alternative targets and delivery strategies. Therefore, the nose to brain delivery emerged as an unorthodox and non-invasive route, which delivers the drug directly to the brain via the olfactory and trigeminal pathways and also bypasses the BBB and hepatic metabolism of the drug...
November 17, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37961995/incorporation-of-exemestane-into-ternary-nanosponge-system-for-enhanced-anti-tumor-potential-in-breast-cancer
#46
JOURNAL ARTICLE
Preeti Tanaji Mane, Balaji Sopanrao Wakure, Pravin Shridhar Wakte
The present investigation reports the potential of exemestane loaded cyclodextrin based nanosponges for the treatment of breast cancer. Fourier transform infrared, and nuclear magnetic resonance (NMR) spectroscopic analysis confirmed the encapsulation of ring B, C, and D of exemestane in the nanosponge cavity. In vitro studies demonstrated a 6.58-folds increase in the aqueous solubility and a 1.76-folds increase in the dissolution of exemestane in the optimized nanosponge formulation EF2. It also exhibited enhanced cytotoxicity in MCF-7 cell line...
November 14, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37943117/crosslinked-hydrogel-loaded-with-chitosan-supported-iron-oxide-and-silver-nanoparticles-as-burn-wound-dressing
#47
JOURNAL ARTICLE
Mina Borhani, Saba Dadpour, Atoosa Haghighizadeh, Leila Etemad, Vahid Soheili, Bahram Memar, Farzad Vafaee, Omid Rajabi
Burns can result in infection, disability, psychosocial and economic issues. Advanced wound dressings like hydrogel absorb exudate and maintain moisture. Considering the antimicrobial properties of silver nanoparticles and iron oxide nanoparticles, the efficiency of cross-linked hydrogel loaded with chitosan-supported iron oxide and silver nanoparticles for burn wounds repair was investigated in animal model. Cellulose hydrogel dressing made from carboxymethylcellulose and hydroxyethylcellulose crosslinked with different concentrations of citric acid (10%, 15%, 20% and 30%) was produced...
November 9, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37938090/effects-of-tableting-process-parameters-and-powder-lubrication-levels-on-tablet-surface-temperature-and-moisture-content
#48
JOURNAL ARTICLE
Komlan Koumbogle, Ryan Gosselin, François Gitzhofer, Nicolas Abatzoglou
Punch sticking is a recurrent problem during the pharmaceutical tableting process. Powder moisture content plays a key role in the buildup of sticking; it evaporates due to increased tablet temperature, accumulates at the punch-tablet interface, and causes sticking through capillary force. This study investigated the effects of compaction pressure (CP), compaction speed (CS), and lubrication level (magnesium stearate [MgSt] ratio) on tablet surface temperature (TST) and moisture content (TSMC). TST and TSMC were measured with an infrared thermal camera and near-infrared sensor, respectively...
November 8, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37937865/review-of-inhalable-nanoparticles-for-the-pulmonary-delivery-of-anti-tuberculosis-drugs
#49
REVIEW
Sowmya Ramachandran, Priyanka Prakash, Noratiqah Mohtar, K Sudesh Kumar, Thaigarajan Parumasivam
Tuberculosis is an airborne disease caused by the pathogen, Mycobacterium tuberculosis , which predominantly affects the lungs. World Health Organization (WHO) has reported that about 85% of TB patients are cured with the existing 6-month antibiotic regimen. However, the lengthy oral administration of high-dose anti-TB drugs is associated with significant side effects and leads to drug resistance cases. Alternatively, reformulating existing anti-tubercular drugs into inhalable nanoparticulate systems is a promising strategy to overcome the challenges associated with oral treatment as they could enhance drug retention in the pulmonary region to achieve an optimal drug concentration in the infected lungs...
November 8, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37921920/in-vitro-evaluation-and-in-vivo-efficacy-studies-of-a-liposomal-doxorubicin-loaded-glycyrretinic-acid-formulation-for-the-treatment-of-hepatocellular-carcinoma
#50
JOURNAL ARTICLE
Mine Diril, Kemal Volkan Özdokur, Yeliz Yıldırım, H Yeşim Karasulu
Hepatocellular carcinoma (HCC), more than 800.000 cases reported annually, is the most common primary liver cancer globally. Doxorubicin hydrochloride (Dox-HCl) is widely used chemotherapy drug for HCC, but efficacy and tolerability are limited, thus critical to develop delivery systems that can target Dox-HCl to the tumour site. In this study, liver-targeting ligand glycyrrhetinic acid (Gly) was conjugated to polyethylene glycol (PEG) via Steglich reaction and incorporated in liposomes, which were then loaded with Dox-HCl by pH gradient method...
November 3, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37889884/scale-up-in-twin-screw-wet-granulation-impact-of-formulation-properties
#51
JOURNAL ARTICLE
Marcel Franke, Thomas Riedel, Robin Meier, Carsten Schmidt, Peter Kleinebudde
The focus of this study was to investigate the sensitivity of different drug formulations to differences in process parameters based on previously developed scale-up strategies. Three different formulations were used for scale-up experiments from a QbCon® 1 with a screw diameter of 16 mm and a throughput of 2kg/h to a QbCon® 25 line with a screw diameter of 25 mm and a throughput of 25kg/h. Two of those formulations were similar in their composition of excipients but had a different API added to the blend to investigate the effect of solubility of the API during twin-screw wet granulation, while the third formulation was based on a controlled release formulation with different excipients and a high fraction of HPMC...
October 27, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37878535/extrusion-based-technologies-for-3d-printing-a-comparative-study-of-the-processability-of-thermoplastic-polyurethane-based-formulations
#52
JOURNAL ARTICLE
Ángela Aguilar-de-Leyva, Vicente Linares, Juan Domínguez-Robles, Marta Casas, Isidoro Caraballo
Thermoplastic polyurethanes (TPU) offer excellent properties for a wide range of dosage forms. These polymers have been successfully utilized in personalized medicine production using Fused Deposition Modeling 3D printing (3DP). However, Direct Powder Extrusion (DPE) has been introduced recently as a challenging technique since it eliminates filament production before 3DP, reducing thermal stress, production time, and costs. This study compares DPE and single-screw extrusion for binary (drug-TPU) and ternary (drug-TPU-magnesium stearate) mixtures containing from 20 to 60% w/w of theophylline...
October 25, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37873604/fast-dissolving-microneedle-patch-for-pronounced-systemic-delivery-of-an-antihyperlipidemic-drug
#53
JOURNAL ARTICLE
Zulcaif Ahmad, Nadiah Zafar, Asif Mahmood, Rai Muhammad Sarfraz, Riffat Latif, Heba A Gad
Fast dissolving microneedles (F-dMN) are quite a novel approach delivering specific drug molecules directly into the bloodstream, bypassing the first-pass effect. The present study reported a F-dMN patch to enhance systemic delivery of simvastatin in a patient friendly manner. The F-dMN patch was developed using polyvinyl pyrrolidone and polyvinyl alcohol and characterized using light microscopy, SEM, XRD, FTIR, mechanical strength, drug content (%), ex-vivo penetration study, an ex-vivo drug release study, a skin irritation test, and a pharmacokinetics study...
October 24, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37870222/sucrose-acetate-isobutyrate-saib-and-glyceryl-monooleate-gmo-hybrid-nanoparticles-for-bioavailability-enhancement-of-rivaroxaban-an-optimization-study
#54
JOURNAL ARTICLE
Adam A Al-Shoubki, Mahmoud H Teaima, Rehab Abdelmonem, Mohamed A El-Nabarawi, Sammar Fathy Elhabal
This study aims to improve the RXB bioavailability using hybrid nanoparticles. A modified melt dispersion technique created different formulas with varying GMO-SAIB: RXB and GMO: SAIB ratios, with fixed GMO-SAIB: poloxamer 407 ratios. The PS, PDI, ZP, and EE were measured to determine the optimal formula, which was selected using Design-Expert™ software. The optimized formula was lyophilized and tested for PS, PDI, ZP, and EE. The chosen lyophilized formula (L4) was characterized using FTIR, DSC, PXRD, dissolution studies and pharmacokinetics study...
October 23, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37869788/design-of-experiments-approach-on-the-compaction-properties-of-co-amorphous-tablets
#55
JOURNAL ARTICLE
Florian Engelsing, Laura Buchart, Holger Grohganz
Co-amorphous systems are an evolving strategy to stabilize the amorphous form of a drug molecule with the aim of overcoming its poor water-solubility. With research focussing on the molecular level of co-amorphous systems, little is known about their downstream processing. In this study, tablets of co-amorphous carvedilol and aspartic acid (CAR-ASP) with calcium hydrogen phosphate and croscarmellose sodium as excipients were produced using a compaction simulator. The amorphous form of spray dried CAR-ASP and the subsequently produced tablets was confirmed with XRPD...
October 23, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37842809/docetaxel-liposomes-for-lung-targeted-delivery%C3%AF-development-and-evaluation
#56
JOURNAL ARTICLE
Yishuai Liu, Zixuan Zhao, Shuhui Zhu, Yumin Cheng, Jun Liu, Tiantian Ye, Shujun Wang
Docetaxel is an artificial semi-synthetic second-generation taxane antitumor drug, which is suitable for the treatment of various cancers such as lung cancer. The route of administration of DTX formulations has been extended to oral, intravenous, and rectal, with few studies on pulmonary administration being reported. Here, we had developed docetaxel liposomes (DTX-lips) for pulmonary inhalation administration. The particle size of the preparation was 125 nm, the encapsulation efficiency was 94.4 ± 0...
October 16, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37830868/electrospun-pva-nanofiber-mat-for-topical-deflazacort-delivery-accentuated-anti-inflammatory-efficacy-for-wound-healing
#57
JOURNAL ARTICLE
Dalia A Mostafa, Amira Mostafa Hashad, Doaa Abou El-Ezz, Mai F Ragab, Maha K A Khalifa
PURPOSE: Asses the wound healing activity of Polyvinyl alcohol - Deflazacort (PVA-DEF) nanofibers mats synthesized by electrospinning technology. METHODS: PVA-DEF nanofiber mats were created with various PVA polymer concentrations using an electrospinning process. The morphological features and diameter of the electrospun nanofibrous mats were investigated using scanning electron microscopy (SEM). The in vitro DEF release rate from PVA electrospun nanofibrous mats was evaluated...
October 13, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37828716/solid-lipid-nanoparticles-of-lutein-with-improved-dissolution-behavior-and-oral-absorption
#58
JOURNAL ARTICLE
Kodai Ueno, Tetsuya Matsushita, Monami Sugihara, Kohei Yamada, Hideyuki Sato, Satomi Onoue
The present study aimed to develop solid lipid nanoparticles of lutein (SLN/LT) with improved dissolution behavior and oral absorption. SLN/LT were prepared by a flash nanoprecipitation method using a multi-inlet vortex mixer, and their physicochemical, photochemical, and pharmacokinetic properties were evaluated. The mean particle size of SLN/LT re-dispersed in water was 237 nm, and small spherical particles with no significant aggregation were observed. LT significantly generated singlet oxygen upon exposure to pseudo-sunlight (250 W/m2 , 1 hour), suggesting its high photoreactivity...
October 12, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37795865/optimizing-formulation-parameters-for-the-development-of-carvedilol-injectable-in-situ-forming-depots
#59
JOURNAL ARTICLE
Majd Alrashdan, Ziad A Shraideh, Samer R Abulateefeh
In situ forming depots (ISFDs) represent attractive alternatives to the conventional sustained drug delivery systems. Carvedilol, a short half-life drug used on daily basis to manage chronic conditions, could benefit from this technology. The aim of this work was to develop, for the first time, a new injectable long-acting carvedilol-ISFD. Accordingly, 4 different grades of polyesters with varying properties as i) lactide to glycolide ratio (polylactide-co-glycolide (PLGA) vs. polylactide (PLA)), and ii) end functionality (acid- vs...
October 5, 2023: Pharmaceutical Development and Technology
https://read.qxmd.com/read/37788221/two-dimensional-printing-of-nanoparticles-as-a-promising-therapeutic-method-for-personalized-drug-administration
#60
REVIEW
Barbara Sterle Zorec
The necessity for personalized patient treatment has drastically increased since the contribution of genes to the differences in physiological and metabolic state of individuals have been exposed. Different approaches have been considered so far in order to satisfy all of the diversities in patient needs, yet none of them have been fully implemented thus far. In this framework, various types of 2D printing technologies have been identified to offer some potential solutions for personalized medication, which development is increasing rapidly...
October 3, 2023: Pharmaceutical Development and Technology
journal
journal
32584
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.